Donor Stem Cell Infusions Preserve CAR-T Benefit in B-ALL

A Chinese team found that DSIs help maintain the efficacy of CAR-T therapy for patients with B-ALL who relapse after transplant. The study was published on as a preprint and has not yet been peer reviewed.
First Look
A Chinese team found that DSIs help maintain the efficacy of CAR-T therapy for patients with B-ALL who relapse after transplant. The study was published on as a preprint and has not yet been peer reviewed.
First Look